The SGC is governed by a Board of Directors, composed of representatives from our major funders, and Scientific Committees that provide direction to our research activities.
The SGC is overseen by its CEO, Aled Edwards. Each of the SGC labs is directed by a Chief Scientist.
SGC Board
|
| Anke Müller-Fahrnow (Chair), ICB Nuvisan |
| Ulrich Betz, Merck KGaA, Darmstadt, Germany |
| Oliver Kraemer, Boehringer Ingelheim |
| Kumar Saikatendu, Takeda |
| Sujata Sharma, Janssen |
| Dafydd Owen, Pfizer |
| Judith Günther, Bayer Pharma |
| Susanne Müller-Knapp (Secretary), SGC-Frankfurt |
SGC Management Team
|
| Aled Edwards CEO |
| Susan McCormick CFO |
| Max Morgan, General Legal Counsel and Director of Public Policy |
| Cheryl Arrowsmith, CSO SGC-Toronto |
| Stefan Knapp, CSO SGC-Frankfurt |
| Michael Sundström, CSO SGC-Karolinska |
| Timothy Willson, CSO SGC-UNC |
| Mat Todd, CSO SGC-UCL |
| Ted Fon, CSO SGC-Neuro |
Chemical Probes
Scientific Committee
|
| Ched Grimshaw, Ched Grimshaw Consulting, LLC (Chair) |
| Lindsey Ingerman, University of North Carolina |
| Paul Thompson University of Massachusetts |
| Jolanta Grembeka University of Michigan |
Joint Management Committee
|
| Hartmut Beck Bayer |
Sujata Sharma Janssen |
Kumar Saikatendu Takeda |
| James Kiefer Genentech |
Dafydd Owen Pfizer |
Jark Böettcher Boehringer Ingelheim |
